speb/financial-data huggingface dataset:
Financial ratios for ANTHEM.NS — annual report dated 2024-03-31
Total revenue: 170208658.1124835
Gross profit: 98311428.22880441
Operating income: 50920853.81940281
Net income: 44047247.871447414
Capital expenditures: 35452572.25086941
Operating cash flow: 16806691.449814126
Depreciation & amortization: 9812207.69876484
Net tangible assets: 230053003.95730904
Owner earnings: 18406883.319342844
Return on net tangible assets (%): 8.00114886687531
Capex to operating income (%): 69.62289433835183
Buffett classification: The Good
Shares outstanding: 561713851
Book value: 230801654.87468523
Debt to equity: 0.12392714538449748
Current ratio: 4.375179770071495
Quick ratio: 3.7510505659619584
Effective tax rate (%): 23.047109055179146
Interest coverage ratio: 45.77716688227684
COGS to revenue (%): 42.24064197496072
R&D to revenue (%): 1.6317802968922834
SG&A to revenue (%): 0.9518307418079854
Free cash flow (dilution-adjusted): -18831274.733181436
Retained earnings: 181864971.81916296
Inventory turnover: 2.836808660638665
Receivables turnover: 2.8940275013864873
Capitalized R&D asset: 5966624.553072736
ROCI (R&D-adjusted, %): 20.017964852601878
Rosenberg metric: 3.460416293201505
FCF margin (%): -11.063640911108449
Revenue growth (%): 32.215096175646444
Rule of 40 score: 21.151455264537994
Financial ratios for ANTHEM.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 262706521.73913044
Buffett classification: The Gruesome
Shares outstanding: 561713851
Book value: 263302675.58528426
Debt to equity: 0.06189115257420488
Current ratio: 4.5597586428124774
Quick ratio: 3.5747527821315552
Retained earnings: 207411371.2374582
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ANTHEM.NS — quarterly report dated 2024-12-31
Total revenue: 58026110.26926215
Gross profit: 30901037.41694836
Operating income: 16229164.238256207
Net income: 14492481.641216924
Capital expenditures: 0
Depreciation & amortization: 2363795.314139177
Owner earnings: 16856276.955356102
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 561713851
Effective tax rate (%): 22.798792906462666
Interest coverage ratio: 54.557210031347964
COGS to revenue (%): 46.74632286473043
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ANTHEM.NS — annual report dated 2025-03-31
Total revenue: 215636310.4980126
Gross profit: 128669745.14846854
Operating income: 69224573.29904138
Net income: 52754267.009586155
Capital expenditures: 30270399.812953003
Operating cash flow: 31628594.80944587
Depreciation & amortization: 10447860.649988309
Net tangible assets: 281271101.23918635
Owner earnings: 32931727.84662146
Return on net tangible assets (%): 11.708180364614526
Capex to operating income (%): 43.72782434091535
Buffett classification: The Good
Shares outstanding: 561713851
Book value: 281723638.0640636
Debt to equity: 0.04702215560712139
Current ratio: 4.561678309674374
Quick ratio: 3.51814807208345
Effective tax rate (%): 31.30126600778238
Interest coverage ratio: 59.12010782747604
COGS to revenue (%): 40.33020466205091
R&D to revenue (%): 1.0584678239118095
SG&A to revenue (%): 0.7848513976014786
Free cash flow (dilution-adjusted): -2922960.0187046994
Retained earnings: 224772737.90039745
Inventory turnover: 2.1851871434698062
Receivables turnover: 4.09540271227986
Capitalized R&D asset: 5182799.868128334
ROCI (R&D-adjusted, %): 23.291202221433053
Rosenberg metric: 10.930357272703215
FCF margin (%): -1.3555045585570054
Revenue growth (%): 26.6893898872688
Rule of 40 score: 25.333885328711794
Financial ratios for ANTHEM.NS — quarterly report dated 2025-03-31
Total revenue: 56487841.94528875
Gross profit: 35813771.33504793
Operating income: 19262450.3156418
Net income: 9658873.041851765
Capital expenditures: 0
Depreciation & amortization: 3556464.8117839606
Net tangible assets: 281271101.23918635
Owner earnings: 13215337.853635725
Return on net tangible assets (%): 4.698434284721526
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 561713851
Book value: 281723638.0640636
Debt to equity: 0.04702215560712139
Current ratio: 4.561678309674374
Quick ratio: 3.51814807208345
Effective tax rate (%): 53.66410372887819
Interest coverage ratio: 316.2591170825336
COGS to revenue (%): 36.59915107088827
Retained earnings: 224772737.90039745
Inventory turnover: 0.5194722031289472
Receivables turnover: 1.07282702333058
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.640377214016562
Revenue growth (%): -2.650993349089368
Rule of 40 score: -2.650993349089368
Financial ratios for ANTHEM.NS — quarterly report dated 2025-06-30
Total revenue: 63211912.005616665
Gross profit: 36196115.14158671
Operating income: 19312660.89398549
Net income: 15889421.951790312
Capital expenditures: 0
Depreciation & amortization: 3094547.156564475
Owner earnings: 18983969.10835479
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 561713851
Effective tax rate (%): 27.091834543189723
Interest coverage ratio: 102.51304347826085
COGS to revenue (%): 42.738458633602924
Capitalized R&D asset: 0
Revenue growth (%): 11.903570447673518
Rule of 40 score: 11.903570447673518
Financial ratios for ANTHEM.NS — quarterly report dated 2025-09-30
Total revenue: 62009808.342728294
Gross profit: 36828184.892897405
Operating income: 20789627.959413752
Net income: 19552311.161217585
Capital expenditures: 0
Depreciation & amortization: 3776662.908680947
Net tangible assets: 309971927.84667414
Owner earnings: 23328974.06989853
Return on net tangible assets (%): 7.526157040078182
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 561713851
Book value: 310320744.08117247
Debt to equity: 0.039969192147630644
Current ratio: 4.706423856899973
Quick ratio: 4.3061389842415
Effective tax rate (%): 24.46570820067682
Interest coverage ratio: 60.83932695480039
COGS to revenue (%): 40.60909737158358
Inventory turnover: 1.2024235703249908
Receivables turnover: 0.9526949551216098
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.5386156448232935
Revenue growth (%): -1.9017043224092922
Rule of 40 score: -1.9017043224092922
Financial ratios for ANTHEM.NS — quarterly report dated 2025-12-31
Total revenue: 47137462.403921135
Gross profit: 31253648.212097585
Operating income: 13664587.27860087
Net income: 10339422.969811741
Capital expenditures: 0
Depreciation & amortization: 3846830.789796146
Owner earnings: 14186253.759607887
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 561713851
Effective tax rate (%): 28.861688918865063
Interest coverage ratio: 348.48579545454544
COGS to revenue (%): 33.69679524899977
Capitalized R&D asset: 0
Revenue growth (%): -23.983860515432788
Rule of 40 score: -23.983860515432788
Financial ratios for ASAL.NS — annual report dated 2023-03-31
Total revenue: 100880803.89768575
Gross profit: 18759403.166869674
Operating income: 2338855.054811206
Net income: 1014043.8489646773
Capital expenditures: 1781973.203410475
Operating cash flow: 3040840.438489647
Depreciation & amortization: 1683398.294762485
Net tangible assets: -3352204.6285018274
Owner earnings: 915468.9403166873
Return on net tangible assets (%): -27.309458752398125
Capex to operating income (%): 76.18998021039474
Buffett classification: The Gruesome
Shares outstanding: 15864397
Book value: -3330353.227771014
Debt to equity: -3.0234984748849736
Current ratio: 0.5879610398611583
Quick ratio: 0.3492141314465108
Effective tax rate (%): 0
Interest coverage ratio: 1.7559485706970026
COGS to revenue (%): 81.40438771097062
SG&A to revenue (%): 1.726667209188157
Free cash flow (dilution-adjusted): 1252070.6455542024
Retained earnings: -11330170.523751523
Inventory turnover: 13.136096092585555
Receivables turnover: 18.339730516712613
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 179.30879922307625
FCF margin (%): 1.2411386479672228
Rule of 40 score: 1.2411386479672228
Financial ratios for ASAL.NS — annual report dated 2024-03-31
Total revenue: 105567442.13934524
Gross profit: 22607890.63436863
Operating income: 4195874.80513251
Net income: 2418767.238277971
Capital expenditures: 1499052.6442019427
Operating cash flow: 3732198.105288404
Depreciation & amortization: 1956625.4946636287
Net tangible assets: -911979.8536994844
Owner earnings: 2876340.088739657
Return on net tangible assets (%): -315.3951347797501
Capex to operating income (%): 35.72682012266572
Buffett classification: The Good
Shares outstanding: 15864397
Book value: -883846.9840508476
Debt to equity: -14.20667806360574
Current ratio: 0.6952468515840217
Quick ratio: 0.4078352295031252
Effective tax rate (%): 0
Interest coverage ratio: 2.627423593902531
COGS to revenue (%): 78.58440995044
SG&A to revenue (%): 1.4575153843418847
Free cash flow (dilution-adjusted): 2216081.0648758844
Retained earnings: -8759911.260342967
Inventory turnover: 10.42900494767405
Receivables turnover: 12.31123122535172
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 64.57848847939877
FCF margin (%): 2.0992088279933285
Revenue growth (%): 4.645718571407028
Rule of 40 score: 6.744927399400357
Financial ratios for ASAL.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 24343.048256091733
Buffett classification: The Gruesome
Shares outstanding: 15864397
Book value: 57787.864309601486
Debt to equity: 204.2377015295646
Current ratio: 0.7182894523004129
Quick ratio: 0.42596912890073774
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ASAL.NS — quarterly report dated 2025-03-31
Total revenue: 21986602.75894318
Gross profit: 6135725.976151507
Operating income: 948187.9822305354
Net income: 576923.0769230769
Capital expenditures: 0
Depreciation & amortization: 592681.7862988075
Net tangible assets: 973591.3023147065
Owner earnings: 1169604.8632218842
Return on net tangible assets (%): 120.13304355135024
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 15864397
Book value: 1021218.1435585655
Debt to equity: 17.02144124549259
Current ratio: 0.738367777677769
Quick ratio: 0.499730193577955
Effective tax rate (%): 0
Interest coverage ratio: 2.2721237078746115
COGS to revenue (%): 72.09334228019488
Retained earnings: -6656885.667523965
Inventory turnover: 2.470553079527275
Receivables turnover: 2.0816438568432236
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.609192453886164
Rule of 40 score: 0
Financial ratios for ASAL.NS — annual report dated 2025-03-31
Total revenue: 90560240.82300678
Gross profit: 22904161.795651156
Operating income: 3519604.8632218842
Net income: 1961526.7711012391
Capital expenditures: 1820353.051204115
Operating cash flow: -785527.2387187281
Depreciation & amortization: 2300409.1653027823
Net tangible assets: 973591.3023147065
Owner earnings: 2441582.8851999063
Return on net tangible assets (%): 250.78109052484962
Capex to operating income (%): 51.72038117761163
Buffett classification: The Good
Shares outstanding: 15864397
Book value: 1021218.1435585655
Debt to equity: 17.02144124549259
Current ratio: 0.738367777677769
Quick ratio: 0.499730193577955
Effective tax rate (%): 0
Interest coverage ratio: 2.093272426404127
COGS to revenue (%): 74.70836916123528
SG&A to revenue (%): 1.5210953352878445
Free cash flow (dilution-adjusted): -2719277.5309796585
Retained earnings: -6656885.667523965
Inventory turnover: 10.545027677663633
Receivables turnover: 8.574047161823383
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 46.80440578628674
FCF margin (%): -3.0027278044614336
Revenue growth (%): -14.21574778380014
Rule of 40 score: -17.218475588261573
Financial ratios for ASAL.NS — quarterly report dated 2025-06-30
Total revenue: 20251392.46431079
Gross profit: 5697776.737655044
Operating income: 660051.486075357
Net income: 297039.5506669787
Capital expenditures: 0
Depreciation & amortization: 598116.0776971683
Owner earnings: 895155.628364147
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 15864397
Effective tax rate (%): 0
Interest coverage ratio: 1.5548388875106811
COGS to revenue (%): 71.86476560712411
Capitalized R&D asset: 0
Revenue growth (%): -7.892125553260305
Rule of 40 score: -7.892125553260305
Financial ratios for ASAL.NS — quarterly report dated 2025-09-30
Total revenue: 23875727.17023675
Gross profit: 7002299.887260429
Operating income: 862829.7632468996
Net income: 495434.04735062004
Capital expenditures: 0
Depreciation & amortization: 555603.1567080045
Net tangible assets: 1737812.852311161
Owner earnings: 1051037.2040586246
Return on net tangible assets (%): 60.48045982976957
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 15864397
Book value: 1778275.084554676
Debt to equity: 7.177191836838212
Current ratio: 0.7893522872985768
Quick ratio: 0.49820343470149586
Effective tax rate (%): 0
Interest coverage ratio: 2.0262370601784436
COGS to revenue (%): 70.67188849439768
Inventory turnover: 2.217911062636705
Receivables turnover: 2.400642279104618
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.01649170232888
Revenue growth (%): 17.896718521025935
Rule of 40 score: 17.896718521025935
Financial ratios for ASAL.NS — quarterly report dated 2025-12-31
Total revenue: 27863161.41249861
Gross profit: 7755107.4969366165
Operating income: 1342698.0060153727
Net income: 831848.0561434778
Capital expenditures: 0
Depreciation & amortization: 545750.2506405258
Owner earnings: 1377598.3067840035
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 15864397
Effective tax rate (%): 0
Interest coverage ratio: 3.363864701942398
COGS to revenue (%): 72.1671658785356
Capitalized R&D asset: 0
Revenue growth (%): 16.700786593141142
Rule of 40 score: 16.700786593141142
Financial ratios for GRDN — annual report dated 2022-12-31
Total revenue: 908909000
Gross profit: 185866000
Operating income: 51990000
Net income: 49661000
Capital expenditures: 16770000
Operating cash flow: 48522000
Depreciation & amortization: 16563000
Net tangible assets: -27759000
Owner earnings: 49454000
Return on net tangible assets (%): -178.1548326668828
Capex to operating income (%): 32.256203115983844
Buffett classification: The Good
Shares outstanding: 49781181
Book value: 75929000
Debt to equity: 0.7482516561524583
Current ratio: 1.0713628855854649
Quick ratio: 0.7013526181866881
Interest coverage ratio: 26.993769470404985
COGS to revenue (%): 79.55064808468174
SG&A to revenue (%): 14.729307334397612
Free cash flow (dilution-adjusted): 35133000
Inventory turnover: 17.446685809424995
Receivables turnover: 13.400796166605234
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 36.07685848906036
FCF margin (%): 3.865403467233793
Rule of 40 score: 3.865403467233793
Financial ratios for GRDN — annual report dated 2023-12-31
Total revenue: 1046193000
Gross profit: 208310000
Operating income: 40946000
Net income: 37720000
Capital expenditures: 14556000
Operating cash flow: 70819000
Depreciation & amortization: 18234000
Net tangible assets: -39816000
Owner earnings: 41398000
Return on net tangible assets (%): -103.97327707454289
Capex to operating income (%): 35.54926000097689
Buffett classification: The Good
Shares outstanding: 49781181
Book value: 59859000
Debt to equity: 1.019078167025844
Current ratio: 0.9390645944281418
Quick ratio: 0.6729558381335362
Effective tax rate (%): 0
Interest coverage ratio: 14.321790835956628
COGS to revenue (%): 80.08875991332384
SG&A to revenue (%): 15.997430684395708
Free cash flow (dilution-adjusted): 62353000
Inventory turnover: 22.813815449124622
Receivables turnover: 13.540848023607984
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 30.751783702591062
FCF margin (%): 5.959990173897168
Revenue growth (%): 15.104262362898815
Rule of 40 score: 21.064252536795983
Financial ratios for IMC.MC — annual report dated 2022-12-31
Total revenue: 837381914.893617
Gross profit: 387907446.80851066
Operating income: 124102127.65957448
Net income: -73043617.0212766
Capital expenditures: 31562765.95744681
Operating cash flow: 162813829.78723404
Depreciation & amortization: 36063829.787234046
Net tangible assets: 1534435106.382979
Owner earnings: -68542553.19148935
Return on net tangible assets (%): -4.466956791223327
Capex to operating income (%): 25.43289672198601
Buffett classification: The Good
Shares outstanding: 454546176
Book value: 2647717021.276595
Debt to equity: 0.3901872106600067
Current ratio: 2.419960728140334
Quick ratio: 0.5403407334520489
Interest coverage ratio: 4.942422573401687
COGS to revenue (%): 53.67616138953858
Free cash flow (dilution-adjusted): 127730851.0638298
Retained earnings: 1716785106.382979
Inventory turnover: 0.4893366657941735
Receivables turnover: 7.16264616224578
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.065001220419925
FCF margin (%): 15.253595616530244
Rule of 40 score: 15.253595616530244
Financial ratios for IMC.MC — annual report dated 2023-12-31
Total revenue: 964081111.111111
Gross profit: 514707777.7777778
Operating income: 235686666.66666666
Net income: 297974444.4444444
Capital expenditures: 48555555.55555555
Operating cash flow: 311282222.2222222
Depreciation & amortization: 38662222.222222224
Net tangible assets: 1938845555.5555556
Owner earnings: 288081111.11111104
Return on net tangible assets (%): 14.858383654419779
Capex to operating income (%): 20.60174054064247
Buffett classification: The Great
Shares outstanding: 454546176
Book value: 2956663333.3333335
Debt to equity: 0.48821400399925285
Current ratio: 1.6522789817142358
Quick ratio: 0.3705954627232438
Effective tax rate (%): 5.666476717108828
Interest coverage ratio: 5.988143296728114
COGS to revenue (%): 46.61156910495083
Free cash flow (dilution-adjusted): 262631111.1111111
Retained earnings: 2141502222.222222
Inventory turnover: 0.4945221023388666
Receivables turnover: 7.968929666978931
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.441565724482607
FCF margin (%): 27.241599081681695
Revenue growth (%): 15.13039557745765
Rule of 40 score: 42.37199465913935
Financial ratios for INTJ — annual report dated 2022-11-30
Total revenue: 1835028.9372599232
Gross profit: 1515911.9078104994
Operating income: 515155.69782330346
Net income: 445455.9539052497
Capital expenditures: 1553.0089628681178
Operating cash flow: 904858.0025608195
Depreciation & amortization: 114197.18309859156
Net tangible assets: 1674054.033290653
Owner earnings: 558100.1280409731
Return on net tangible assets (%): 33.33823860774239
Capex to operating income (%): 0.3014639980553596
Buffett classification: The Great
Shares outstanding: 1462500
Book value: 1674054.033290653
Debt to equity: 0.2802221630393896
Current ratio: 3.6754850500376235
Quick ratio: 3.6754850500376235
Effective tax rate (%): 12.838198745314974
Interest coverage ratio: 41.40671215536139
COGS to revenue (%): 17.39029957347329
SG&A to revenue (%): 49.39557240599359
Free cash flow (dilution-adjusted): 903304.9935979514
Retained earnings: 1416566.581306018
Receivables turnover: 5.200302477002168
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 25.10283552006996
FCF margin (%): 49.22565389877568
Rule of 40 score: 49.22565389877568
Financial ratios for INTJ — annual report dated 2023-11-30
Total revenue: 2633233.076923077
Gross profit: 2055607.0512820513
Operating income: 529966.1538461539
Net income: 521663.9743589744
Capital expenditures: 4022.6923076923076
Operating cash flow: 349869.358974359
Depreciation & amortization: 115236.15384615384
Net tangible assets: 2197864.230769231
Owner earnings: 632877.435897436
Return on net tangible assets (%): 28.795110591336893
Capex to operating income (%): 0.7590470218707726
Buffett classification: The Great
Shares outstanding: 1462500
Book value: 2197864.230769231
Debt to equity: 0.23982863083689462
Current ratio: 2.1613591261799807
Quick ratio: 2.1613591261799807
Effective tax rate (%): 11.536319213567081
Interest coverage ratio: 38.18376301277492
COGS to revenue (%): 21.93600067928584
SG&A to revenue (%): 46.610961527357084
Free cash flow (dilution-adjusted): 345846.6666666667
Retained earnings: 1940046.6666666667
Receivables turnover: 3.789146099835072
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.740447132189157
FCF margin (%): 13.133917756751986
Revenue growth (%): 43.49817724700501
Rule of 40 score: 56.632095003756994
Financial ratios for KSM.V — annual report dated 2023-07-31
Capital expenditures: 0
Net tangible assets: 849215.0375939849
Buffett classification: The Gruesome
Shares outstanding: 41216666
Book value: 849215.0375939849
Debt to equity: 0.5823555764899209
Current ratio: 14.016124754680952
Quick ratio: 14.016124754680952
Retained earnings: -53457.8947368421
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KSM.V — quarterly report dated 2024-10-31
Total revenue: 0
Operating income: -31192.086330935253
Net income: -65806.47482014389
Capital expenditures: 0
Operating cash flow: -31210.071942446044
Owner earnings: -65806.47482014389
Buffett classification: The Gruesome
Shares outstanding: 41216666
Interest coverage ratio: -0.8400402999244376
Free cash flow (dilution-adjusted): -31210.071942446044
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1333.HK — annual report dated 2022-12-31
Total revenue: 46226742.49037227
Gross profit: 1049103.7227214377
Operating income: -18099582.67008986
Net income: -19040212.45186136
Capital expenditures: 1935607.8305519896
Operating cash flow: -37281211.03979461
Depreciation & amortization: 970449.5507060334
Net tangible assets: 70976196.53401797
Owner earnings: -20005370.731707316
Return on net tangible assets (%): -28.186028145533275
Buffett classification: The Gruesome
Shares outstanding: 250530731
Book value: 71108636.20025674
Debt to equity: 0.29255844403301007
Current ratio: 2.704805776868847
Quick ratio: 1.7428375394733981
Interest coverage ratio: -10.266929949756063
COGS to revenue (%): 97.73052638753437
R&D to revenue (%): 12.456080332540898
SG&A to revenue (%): 7.846293751842024
Free cash flow (dilution-adjusted): -42946449.67907574
Retained earnings: -18836499.743260592
Inventory turnover: 1.1948420442554277
Receivables turnover: 1.9034955588755635
Capitalized R&D asset: 5758040.179717586
ROCI (R&D-adjusted, %): -16.668432027051626
FCF margin (%): -92.90390662508888
Rule of 40 score: -92.90390662508888
Financial ratios for 1333.HK — annual report dated 2023-12-31
Total revenue: 59377468.758002564
Gross profit: 1188088.9884763125
Operating income: -25662246.991037134
Net income: -29374331.75416133
Capital expenditures: 11987196.030729834
Operating cash flow: -24799700
Depreciation & amortization: 1510071.19078105
Net tangible assets: 117830421.63892446
Owner earnings: -39851456.59411012
Return on net tangible assets (%): -33.82102519859393
Buffett classification: The Gruesome
Shares outstanding: 250530731
Book value: 118092130.60179257
Debt to equity: 0.20243816667196865
Current ratio: 2.648692411905626
Quick ratio: 2.019736603481578
Interest coverage ratio: -28.966924266512503
COGS to revenue (%): 97.99909121535904
R&D to revenue (%): 14.784542654859376
SG&A to revenue (%): 9.78871625044701
Free cash flow (dilution-adjusted): -50404531.37003842
Retained earnings: -48162594.62227913
Inventory turnover: 1.6914852463460432
Receivables turnover: 1.4232493086021678
Capitalized R&D asset: 12636574.116313472
ROCI (R&D-adjusted, %): -15.52179107832839
Rosenberg metric: 0.02413759915126045
FCF margin (%): -84.88831272930472
Revenue growth (%): 28.448308401504217
Rule of 40 score: -56.440004327800494
Financial ratios for 1333.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 87541237.11340207
Buffett classification: The Gruesome
Shares outstanding: 250530731
Book value: 87922809.27835053
Debt to equity: 0.5395738705899767
Current ratio: 1.5330972732808588
Quick ratio: 1.1436387830126975
Retained earnings: -83852706.185567
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1333.HK — annual report dated 2024-12-31
Total revenue: 81888788.65979382
Gross profit: 4747293.81443299
Operating income: -26494845.36082474
Net income: -35379768.041237116
Capital expenditures: 10398969.072164949
Operating cash flow: -34787500
Depreciation & amortization: 2440592.783505155
Net tangible assets: 87541237.11340207
Owner earnings: -43338144.32989691
Return on net tangible assets (%): -49.5059765648001
Buffett classification: The Gruesome
Shares outstanding: 250530731
Book value: 87922809.27835053
Debt to equity: 0.5395738705899767
Current ratio: 1.5330972732808588
Quick ratio: 1.1436387830126975
Interest coverage ratio: -22.379449221726354
COGS to revenue (%): 94.20275486775658
R&D to revenue (%): 12.8579903911673
SG&A to revenue (%): 26.59251530788078
Free cash flow (dilution-adjusted): -54343814.432989694
Retained earnings: -83852706.185567
Inventory turnover: 2.311061179895222
Receivables turnover: 1.628153720410051
Capitalized R&D asset: 18311126.257881194
ROCI (R&D-adjusted, %): -20.618394159857022
Rosenberg metric: 0.40543702566573725
FCF margin (%): -66.36294824040021
Revenue growth (%): 37.912225584316964
Rule of 40 score: -28.45072265608325
Financial ratios for 483A.T — annual report dated 2024-03-31
Total revenue: 25837202.8526149
Gross profit: 6152489.434759641
Operating income: 3029047.8077126257
Net income: 2169875.8584257793
Capital expenditures: 121500.26413100898
Operating cash flow: 2602086.634970946
Depreciation & amortization: 88351.82250396197
Net tangible assets: 13998936.872688854
Owner earnings: 2136727.4167987322
Return on net tangible assets (%): 15.263497765800832
Capex to operating income (%): 4.01117023711684
Buffett classification: The Great
Shares outstanding: 1630000
Book value: 14015312.995245641
Debt to equity: 0.007818216340420802
Current ratio: 3.460642980631839
Quick ratio: 3.4586101472933715
Effective tax rate (%): 28.744313327521976
Interest coverage ratio: 2479.562162162162
COGS to revenue (%): 76.18747869165345
SG&A to revenue (%): 12.370443975213568
Free cash flow (dilution-adjusted): 2480586.3708399367
Retained earnings: 13937196.249339672
Inventory turnover: 1963.80303030303
Receivables turnover: 5.980749889182704
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 21.159425771638972
FCF margin (%): 9.600831734728144
Rule of 40 score: 9.600831734728144
Financial ratios for 483A.T — annual report dated 2025-03-31
Total revenue: 29321908.83571715
Gross profit: 7008956.021922203
Operating income: 3454130.463841732
Net income: 2504063.627857238
Capital expenditures: 129461.30196497795
Operating cash flow: 2880156.396203716
Depreciation & amortization: 117003.07445528673
Net tangible assets: 16383030.34353696
Owner earnings: 2491605.400347547
Return on net tangible assets (%): 15.208452576238289
Capex to operating income (%): 3.748014249033005
Buffett classification: The Great
Shares outstanding: 1630000
Book value: 16395722.49699238
Debt to equity: 0.0017985200935295672
Current ratio: 3.475509521753062
Quick ratio: 3.4745239123469354
Effective tax rate (%): 27.97573161752691
Interest coverage ratio: 5497.946808510637
COGS to revenue (%): 76.0964992259201
SG&A to revenue (%): 12.351406746621493
Free cash flow (dilution-adjusted): 2749224.702579869
Retained earnings: 16287281.11215078
Inventory turnover: 3932.229681978799
Receivables turnover: 6.762238139497604
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.714072713105963
FCF margin (%): 9.37600862884829
Revenue growth (%): 13.48716423747695
Rule of 40 score: 22.86317286632524
Financial ratios for 483A.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 17079360.699865412
Buffett classification: The Gruesome
Shares outstanding: 1630000
Book value: 17090188.425302826
Debt to equity: 0.00029965325275377796
Current ratio: 3.8000741043112383
Quick ratio: 3.7993644613307374
Retained earnings: 16981002.69179004
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 81D.DE — annual report dated 2021-06-30
Total revenue: 617963.0434782609
Gross profit: 580169.5652173912
Operating income: -5027614.130434782
Net income: -5041608.695652174
Capital expenditures: 6294.565217391304
Operating cash flow: -2277161.9565217393
Depreciation & amortization: 130223.91304347826
Net tangible assets: 534291.304347826
Owner earnings: -4917679.347826087
Return on net tangible assets (%): -920.4116383344049
Buffett classification: The Gruesome
Shares outstanding: 8484798
Book value: 684890.2173913042
Debt to equity: 0.1936949590461182
Current ratio: 2.6222298757387255
Quick ratio: 2.574869170585708
Interest coverage ratio: -509.91125564987317
COGS to revenue (%): 6.115815283733725
SG&A to revenue (%): 335.2342724870982
Free cash flow (dilution-adjusted): -5115963.04347826
Retained earnings: -4318794.565217391
Inventory turnover: 2.2375957268807514
Receivables turnover: 18.130752304110725
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -670.251412838719
FCF margin (%): -827.8752422932283
Rule of 40 score: -827.8752422932283
Financial ratios for AEXA — quarterly report dated 2025-07-31
Capital expenditures: 0
Net tangible assets: 7578
Buffett classification: The Gruesome
Shares outstanding: 34675000
Book value: 7578
Debt to equity: 3.0126682501979416
Current ratio: 1.4824120603015076
Quick ratio: 1.4824120603015076
Retained earnings: -17422
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCIX — annual report dated 2023-12-31
Capital expenditures: 0
Net tangible assets: 6042
Buffett classification: The Gruesome
Shares outstanding: 29475000
Book value: 6042
Debt to equity: 6.206554121151936
Current ratio: 0
Quick ratio: 0
Retained earnings: -18958
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GENO.OL — annual report dated 2023-12-31
Total revenue: 79446856.58153242
Gross profit: 55086738.70333988
Operating income: 6960707.269155206
Net income: -7124263.261296661
Capital expenditures: 2348624.7544204323
Operating cash flow: 4689194.499017682
Depreciation & amortization: 4926227.8978389
Net tangible assets: 36667387.03339882
Owner earnings: -4546660.117878193
Return on net tangible assets (%): -12.399738529873499
Capex to operating income (%): 33.741179791137455
Buffett classification: The Good
Shares outstanding: 187612016
Book value: 61422396.85658154
Debt to equity: 0.35339048106448306
Current ratio: 2.9592944593855792
Quick ratio: 1.8230957416846607
Interest coverage ratio: 1.975632196726796
COGS to revenue (%): 30.662154459431555
Free cash flow (dilution-adjusted): 1646561.8860510807
Retained earnings: 2084282.9076620825
Inventory turnover: 1.2053133991756748
Receivables turnover: 5.27225376627271
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.18814948514959
FCF margin (%): 2.0725324536425114
Rule of 40 score: 2.0725324536425114
Financial ratios for GENO.OL — annual report dated 2024-12-31
Total revenue: 84472021.1827008
Gross profit: 56244748.455428064
Operating income: 5627978.817299206
Net income: 3458252.427184466
Capital expenditures: 1382700.7943512797
Operating cash flow: 11488967.343336275
Depreciation & amortization: 5313062.66548985
Net tangible assets: 35250044.130626656
Owner earnings: 7388614.298323035
Return on net tangible assets (%): 20.960581697268033
Capex to operating income (%): 24.56833686191484
Buffett classification: The Great
Shares outstanding: 187612016
Book value: 63405913.50397175
Debt to equity: 0.3831225144037562
Current ratio: 1.6613077229766178
Quick ratio: 1.1112619901967684
Effective tax rate (%): 35.403992943930625
Interest coverage ratio: 1.3578577512776833
COGS to revenue (%): 33.41612090258999
Free cash flow (dilution-adjusted): 9910238.305383936
Retained earnings: 4448367.166813768
Inventory turnover: 1.363618920924045
Receivables turnover: 5.07965522365879
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.165645357585538
FCF margin (%): 11.731977247175749
Revenue growth (%): 6.325189966466828
Rule of 40 score: 18.05716721364258
Financial ratios for GENO.OL — quarterly report dated 2025-03-31
Total revenue: 32601526.71755725
Gross profit: 20158110.6870229
Operating income: 5413263.358778626
Net income: 4201526.717557251
Capital expenditures: 2934828.244274809
Operating cash flow: 11656774.809160305
Depreciation & amortization: 1623187.0229007632
Owner earnings: 2889885.4961832054
Capex to operating income (%): 54.215508275898536
Buffett classification: The Good
Shares outstanding: 187612016
Effective tax rate (%): 25.784594640148324
Interest coverage ratio: 14.628932439401755
COGS to revenue (%): 38.16820033717336
R&D to revenue (%): 0.7680059941931254
SG&A to revenue (%): 3.41797789641285
Free cash flow (dilution-adjusted): 8297041.984732824
Capitalized R&D asset: 250381.67938931298
ROCI (R&D-adjusted, %): 2228.6712398373984
FCF margin (%): 25.449857169616934
Rule of 40 score: 25.449857169616934
Financial ratios for GENO.OL — annual report dated 2025-12-31
Total revenue: 127403980.09950247
Gross profit: 81726368.15920398
Operating income: 18070547.26368159
Net income: 16425970.14925373
Capital expenditures: 3571243.7810945273
Operating cash flow: 20737910.447761193
Depreciation & amortization: 6449552.238805969
Net tangible assets: 43380696.51741293
Owner earnings: 19304278.60696517
Return on net tangible assets (%): 44.49969723104024
Capex to operating income (%): 19.762787086543067
Buffett classification: The Great
Shares outstanding: 187612016
Book value: 70432139.30348258
Debt to equity: 0.22434777203419404
Current ratio: 1.5482635399637035
Quick ratio: 1.0911463410975957
Effective tax rate (%): 11.840193963215347
Interest coverage ratio: 21.35822650829119
COGS to revenue (%): 35.85257847095853
R&D to revenue (%): 1.2098468459321623
SG&A to revenue (%): 4.131723432338079
Free cash flow (dilution-adjusted): 17049950.24875622
Retained earnings: 17460796.019900497
Inventory turnover: 1.8827901024940632
Receivables turnover: 7.111492490891317
Capitalized R&D asset: 1541393.0348258705
ROCI (R&D-adjusted, %): 22.999608557414238
FCF margin (%): 13.382588389656439
Revenue growth (%): 50.8238802809584
Rule of 40 score: 64.20646867061484
Financial ratios for GODAVARIB.NS — annual report dated 2023-03-31
Total revenue: 245395127.89281365
Gross profit: 46137149.81729598
Operating income: 12427405.602923265
Net income: 2391839.2204628503
Capital expenditures: 26452618.757612668
Operating cash flow: 23990255.785627287
Depreciation & amortization: 6099390.986601706
Net tangible assets: 58444579.78075518
Owner earnings: -17961388.550548114
Return on net tangible assets (%): -30.73234270470792
Capex to operating income (%): 212.8571288555215
Buffett classification: The Gruesome
Shares outstanding: 51175977
Book value: 59616077.953715
Debt to equity: 1.5035141628937085
Current ratio: 1.0727624590533034
Quick ratio: 0.3968793964421112
Effective tax rate (%): 38.15433070866142
Interest coverage ratio: 1.5308636418197095
COGS to revenue (%): 81.19883217997373
SG&A to revenue (%): 5.464403030931745
Free cash flow (dilution-adjusted): -2481120.5846528625
Retained earnings: 19617174.177831914
Inventory turnover: 3.150017426198605
Receivables turnover: 9.971708712588038
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.462956791041332
FCF margin (%): -1.011071656539405
Rule of 40 score: -1.011071656539405
Financial ratios for GODAVARIB.NS — annual report dated 2024-03-31
Total revenue: 202262297.6376064
Gross profit: 39696186.59311668
Operating income: 8929523.923731862
Net income: 1474793.1406643481
Capital expenditures: 6609005.876004317
Operating cash flow: 22205204.460966542
Depreciation & amortization: 7186125.434704401
Net tangible assets: 58467502.09857297
Owner earnings: 2051912.6993644321
Return on net tangible assets (%): 3.5094926680893956
Capex to operating income (%): 74.01297014771035
Buffett classification: The Good
Shares outstanding: 51175977
Book value: 60040628.37270656
Debt to equity: 1.3074034690504173
Current ratio: 0.9700675923893038
Quick ratio: 0.24434663153838032
Effective tax rate (%): 1.1859327167983031
Interest coverage ratio: 1.056860131910056
COGS to revenue (%): 80.37390702233573
SG&A to revenue (%): 4.454867246038678
Free cash flow (dilution-adjusted): 15572622.616620697
Retained earnings: 20692469.120997723
Inventory turnover: 1.6835810218805867
Receivables turnover: 8.88654940626913
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.442865952709573
FCF margin (%): 7.699221653519523
Revenue growth (%): -17.57688941324347
Rule of 40 score: -9.877667759723948
Financial ratios for GODAVARIB.NS — quarterly report dated 2024-09-30
Capital expenditures: 2114225.9913999042
Operating cash flow: 5620293.836598185
Depreciation & amortization: 1474904.4433827042
Buffett classification: The Gruesome
Shares outstanding: 51175977
Free cash flow (dilution-adjusted): 3506067.84519828
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GUJTHEM.NS — annual report dated 2023-03-31
Total revenue: 18042594.397076737
Gross profit: 14293386.11449452
Operating income: 8832009.744214373
Net income: 7060755.176613886
Capital expenditures: 2886991.473812424
Operating cash flow: 4808319.123020707
Depreciation & amortization: 313727.16199756396
Net tangible assets: 18166382.46041413
Owner earnings: 4487490.864799026
Return on net tangible assets (%): 24.702171027047328
Capex to operating income (%): 32.687820297114364
Buffett classification: The Good
Shares outstanding: 108965265
Book value: 18166382.46041413
Debt to equity: 0.002809998256741716
Current ratio: 4.040371247921876
Quick ratio: 3.083530782422013
Effective tax rate (%): 25.167559975627636
Interest coverage ratio: 764.8818565400844
COGS to revenue (%): 20.779762599937758
R&D to revenue (%): 1.9796165117461253
SG&A to revenue (%): 1.6526057907360912
Free cash flow (dilution-adjusted): 1921327.6492082828
Retained earnings: 16998818.514007308
Inventory turnover: 2.1055763810983117
Receivables turnover: 8.272952701155523
Capitalized R&D asset: 396934.1672819981
ROCI (R&D-adjusted, %): 48.152383098916204
FCF margin (%): 10.648843547242722
Rule of 40 score: 10.648843547242722
Financial ratios for GUJTHEM.NS — annual report dated 2024-03-31
Total revenue: 20364779.94963425
Gross profit: 15375272.81448615
Operating income: 9059515.52943998
Net income: 7094759.5634968225
Capital expenditures: 8951265.139705
Operating cash flow: 7700335.771675261
Depreciation & amortization: 487288.64372226887
Net tangible assets: 24148710.87660391
Owner earnings: -1369216.9324859092
Return on net tangible assets (%): -5.669937991648461
Capex to operating income (%): 98.80511944172724
Buffett classification: The Gruesome
Shares outstanding: 108965265
Book value: 24148710.87660391
Debt to equity: 0.013747410939033977
Current ratio: 2.9433449675726524
Quick ratio: 2.7374684390316353
Effective tax rate (%): 25.42544649666033
Interest coverage ratio: 530.1564912280701
COGS to revenue (%): 24.500668052824754
R&D to revenue (%): 2.2978779533146194
SG&A to revenue (%): 1.078423925300565
Free cash flow (dilution-adjusted): -1250929.3680297397
Retained earnings: 22999208.538194027
Inventory turnover: 12.506763255981726
Receivables turnover: 6.2837653327413
Capitalized R&D asset: 726847.766236926
ROCI (R&D-adjusted, %): 36.48600821146742
Rosenberg metric: 3.0290171214470347
FCF margin (%): -6.142611759731812
Revenue growth (%): 12.870574494174484
Rule of 40 score: 6.727962734442672
Financial ratios for GUJTHEM.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 26666005.733397037
Buffett classification: The Gruesome
Shares outstanding: 108965265
Book value: 26688772.09746775
Debt to equity: 0.015201057651683865
Current ratio: 2.526533138618362
Quick ratio: 2.302261143724794
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MLMAC.LS — annual report dated 2021-12-31
Total revenue: 519318.1818181818
Gross profit: 469318.1818181818
Operating income: -4850000
Net income: -5022727.2727272725
Capital expenditures: 0
Operating cash flow: -985227.2727272727
Depreciation & amortization: 113636.36363636363
Net tangible assets: 5746590.909090909
Owner earnings: -4909090.909090909
Return on net tangible assets (%): -85.4261419814119
Buffett classification: The Gruesome
Shares outstanding: 70446883
Book value: 5746590.909090906
Debt to equity: 5.712675499307893
Current ratio: 6.549901725267525
Quick ratio: 6.3448351168377375
Interest coverage ratio: -170.72
COGS to revenue (%): 9.62800875273523
SG&A to revenue (%): 890.3719912472648
Free cash flow (dilution-adjusted): -985227.2727272727
Retained earnings: -5229545.454545454
Inventory turnover: 0.04685835995740149
Receivables turnover: 11.717948717948719
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.742502320950446
FCF margin (%): -189.7155361050328
Rule of 40 score: -189.7155361050328
Financial ratios for MLMAC.LS — annual report dated 2022-12-31
Total revenue: 5231914.893617022
Gross profit: 5146808.5106382985
Operating income: -1991489.3617021278
Net income: -5907446.808510639
Capital expenditures: 0
Operating cash flow: -1664893.6170212766
Depreciation & amortization: 1247872.340425532
Net tangible assets: 69464893.61702128
Owner earnings: -4659574.468085106
Return on net tangible assets (%): -6.7078119974884
Buffett classification: The Gruesome
Shares outstanding: 70446883
Book value: 69464893.61702126
Debt to equity: 1.5181095609292927
Current ratio: 2.193593153694923
Quick ratio: 1.980918237539031
Interest coverage ratio: -0.6151823858034835
COGS to revenue (%): 1.6266775111834078
SG&A to revenue (%): 85.4615697437983
Free cash flow (dilution-adjusted): -1664893.6170212766
Retained earnings: -10802127.65957447
Inventory turnover: 0.043501903208265365
Receivables turnover: 26.440860215053764
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.6941817777283347
FCF margin (%): -31.821878812525412
Revenue growth (%): 907.45844778621
Rule of 40 score: 875.6365689736846
Financial ratios for MLMAC.LS — annual report dated 2023-12-31
Total revenue: 23026666.666666668
Gross profit: 22483333.333333332
Operating income: 5213333.333333333
Net income: -5217777.777777778
Capital expenditures: 278888.8888888889
Operating cash flow: 3922222.222222222
Depreciation & amortization: 3872222.222222222
Net tangible assets: 149257777.77777776
Owner earnings: -1624444.444444445
Return on net tangible assets (%): -1.0883482714468635
Capex to operating income (%): 5.349531116794544
Buffett classification: The Great
Shares outstanding: 70446883
Book value: 149257777.7777778
Debt to equity: 1.4874936723937706
Current ratio: 5.09606501283148
Quick ratio: 5.09606501283148
Interest coverage ratio: 0.4765871000507872
COGS to revenue (%): 2.3595830920671688
SG&A to revenue (%): 42.443543717429066
Free cash flow (dilution-adjusted): 3643333.333333333
Retained earnings: -14266666.666666666
Receivables turnover: 20.1399416909621
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9164599488251263
FCF margin (%): 15.822235089751011
Revenue growth (%): 340.1192896841534
Rule of 40 score: 355.9415247739044
Financial ratios for OMH — annual report dated 2022-12-31
Total revenue: 5242979.104477611
Gross profit: 1729040.2985074625
Operating income: -2226323.134328358
Net income: -2278358.2089552237
Capital expenditures: 11438.059701492537
Operating cash flow: -2318147.014925373
Depreciation & amortization: 241352.98507462686
Net tangible assets: -1329303.7313432836
Owner earnings: -2048443.2835820895
Buffett classification: The Gruesome
Shares outstanding: 22259591
Book value: -1629185.0746268653
Debt to equity: -1.7569318604484985
Current ratio: 0.17587648874137063
Quick ratio: 0.17587648874137063
Interest coverage ratio: -76.19720576215774
COGS to revenue (%): 67.02179688202789
R&D to revenue (%): 25.161296016051033
SG&A to revenue (%): 48.96993733766493
Free cash flow (dilution-adjusted): -2329585.0746268653
Retained earnings: -9799636.567164179
Receivables turnover: 28.826962530158053
Capitalized R&D asset: 1319201.4925373134
ROCI (R&D-adjusted, %): -357.4329775084335
FCF margin (%): -44.43246917839806
Rule of 40 score: -44.43246917839806
Financial ratios for PNGJL.NS — annual report dated 2023-03-31
Total revenue: 549027892.8136419
Gross profit: 43495006.09013399
Operating income: 19714372.71619976
Net income: 11413032.886723509
Capital expenditures: 5699634.591961023
Operating cash flow: 12761510.353227772
Depreciation & amortization: 2623264.31181486
Net tangible assets: 42281242.38733252
Owner earnings: 8336662.606577345
Return on net tangible assets (%): 19.717165664637644
Capex to operating income (%): 28.911062370640384
Buffett classification: The Good
Shares outstanding: 135708333
Book value: 44547381.24238734
Debt to equity: 0.8862752710986672
Current ratio: 1.5004087400609978
Quick ratio: 0.432706360066901
Effective tax rate (%): 20.648860133464314
Interest coverage ratio: 4.748151842290542
COGS to revenue (%): 92.07781486888908
SG&A to revenue (%): 0.8466298200850625
Free cash flow (dilution-adjusted): 6920341.047503046
Retained earnings: 33794518.87941535
Inventory turnover: 6.953498424314313
Receivables turnover: 114.1172941087116
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 32.14489282387685
FCF margin (%): 1.2604716696701668
Rule of 40 score: 1.2604716696701668
Financial ratios for PNGJL.NS — annual report dated 2024-03-31
Total revenue: 732944237.9182156
Gross profit: 61136347.28384698
Operating income: 30514210.33697086
Net income: 18605228.44465763
Capital expenditures: 3117.8798417076387
Operating cash flow: 758124.4753567574
Depreciation & amortization: 2781268.737258664
Net tangible assets: 59992924.81112843
Owner earnings: 21383379.30207459
Return on net tangible assets (%): 35.64316853928092
Capex to operating income (%): 0.010217796257142633
Buffett classification: The Great
Shares outstanding: 135708333
Book value: 64089219.33085501
Debt to equity: 0.8517214280368237
Current ratio: 1.5460317216404285
Quick ratio: 0.31817169024148506
Effective tax rate (%): 25.922336123299644
Interest coverage ratio: 6.395827573205982
COGS to revenue (%): 91.65879965746197
SG&A to revenue (%): 0.8659327469698244
Free cash flow (dilution-adjusted): -2899988.008154455
Retained earnings: 51562657.392972775
Inventory turnover: 5.842581487561245
Receivables turnover: 161.73221137307826
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 37.19363175004092
FCF margin (%): -0.39566284283662595
Revenue growth (%): 33.49854306345797
Rule of 40 score: 33.102880220621344
Financial ratios for PROSTARM.NS — annual report dated 2022-03-31
Capital expenditures: 0
Net tangible assets: 5046234.99934063
Buffett classification: The Gruesome
Shares outstanding: 58874592
Book value: 5769563.497296584
Debt to equity: 0.07335670825085829
Current ratio: 1.5995687984590485
Quick ratio: 0.9826915623557548
Retained earnings: 4172899.9076882503
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PROSTARM.NS — annual report dated 2023-03-31
Total revenue: 28027819.732034106
Gross profit: 6997417.783191231
Operating income: 3214470.1583434837
Net income: 2434299.6345919613
Capital expenditures: 1421961.0231425092
Operating cash flow: -1644713.7637028017
Depreciation & amortization: 200730.81607795373
Net tangible assets: 7126638.246041413
Owner earnings: 1213069.4275274058
Return on net tangible assets (%): 17.02162205583006
Capex to operating income (%): 44.23624899586219
Buffett classification: The Good
Shares outstanding: 58874592
Book value: 7693130.328867236
Debt to equity: 0.39346522990598565
Current ratio: 1.4314705012130895
Quick ratio: 0.9381016628202853
Effective tax rate (%): 26.12922564656736
Interest coverage ratio: 23.202743098294356
COGS to revenue (%): 75.03402744097998
R&D to revenue (%): 0.0016948533821451108
SG&A to revenue (%): 1.2139930571852222
Free cash flow (dilution-adjusted): -3092777.1010962245
Retained earnings: 2172679.658952497
Inventory turnover: 4.141789326220039
Receivables turnover: 3.3824697154331123
Capitalized R&D asset: 475.0304506699148
ROCI (R&D-adjusted, %): 37.22854450769864
FCF margin (%): -11.034668877798465
Rule of 40 score: -11.034668877798465